Have You Seen This Man on TV This Week?
He's been all over CNBC with his latest findings that Nvidia, Amazon and Tesla are ticking time bombs in investors' portfolios. He's a futurist known for making contrarian and highly accurate calls over the past 30+ years. Today, he's sharing the three stocks positioned to take over as the tech kingpins of tomorrow.
Shares Stats
| Shares Outstanding | 196,130,000 |
| Shares Float | 193,970,000 |
| Shares Short | 9,360,000 |
| Insider Holdings | 202% |
| Institution Holdings | 104.17% |
About Incyte Corp
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI (ruxolitinib) for the treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for treating relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a selective fibroblast growth factor receptor kinase inhibitor for the treatment of unresectable biliary tract cancer, metastatic cholangiocarcinoma, and myeloid/lymphoid neoplasms; ICLUSIG (ponatinib), a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma; and NIKTIMVO (axatilimab-csfr) for treating chronic graft-versus-host disease, as well as OPZELURA (ruxolitinib) cream for treating atopic dermatitis. Its clinical stage products include INCB123667 (CDK2) for ovarian cancer; INCB161734 (KRASG12D) for cancers; INCA33890 (TGFßR2xPD-1) for solid tumors; Ruxolitinib cream for mild to moderate hidradenitis suppurativa (HS); Povorcitinib for HS, nonsegmental vitiligo, prurigo nodularis, and asthma and chronic spontaneous urticaria; INCB000262 (MRGPRX2) and INCB000547 (MRGPRX4) for systemic immune and neuro-immune disorders; INCA034460 (anti-CD122) for vitiligo; and Zilurgisertib (ALK2) for fibrodysplasia ossificans progressive. It has collaboration with Genesis Therapeutics, Inc. The company sells its products to specialty and retail pharmacies, hospital pharmacies, and specialty distributors and wholesalers. The company was formerly known as Incyte Genomics Inc and changed its name to Incyte Corporation in March 2003. Incyte Corporation was incorporated in 1991 and is headquartered in Wilmington, Delaware.
General
| Name | Incyte Corp |
| Ticker | INCY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 2,617 |
Highlights
| Analyst Target | 93.62 |
| Market Cap | 20,653,200,000 |
| PE Ratio | 17.65 |
| PEG Ratio | 0.13 |
| EBITDA | 1,324,280,064 |
Financials
| Curr Year EPS Estimate | 6.84 |
| Next Quarter EPS Estimate | 1.74 |
| Profit Margin | 24.69% |
| Operating Margin | 26.10 |
| Return on Assets | 0.14 |
| Return on Equity | 0.30 |
| Revenue | 4.8B |
| Earnings Per Share | 5.90 |
| Revenue Per Share | 24.79 |
| Gross Profit | 2,718,851,072 |
| Quarterly Revenue Growth | 0.20 |
Valuation
| Trailing PE | 17.92 |
| Forward PE | 12.50 |
| Price/Sales (Trailing 12 Mt.) | 4.31 |
| Price/Book (Most Recent Quarter) | 4.04 |
Earnings
IRS Direct File won't be available next year. Here's what that means for taxpayers
WASHINGTON (AP) — IRS Direct File, the electronic system for filing tax returns for free, will not be offered next year, the Trump administration has confirmed.
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today
PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.
Texas Is All-in on AI Data Centers. Guess Who Benefits... - Ad
The state of Texas recently made a critical change to its laws... In a quest to become the AI data center capital of the world. Now, these giant buildings are popping up everywhere in Texas...
Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are
Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.
Denny's to be acquired and taken private in a deal valued at $620 million
Denny's said Monday that it's being acquired by a group on investors in a deal that will take the breakfast chain private.
Why Aren't You Invested in the Texas Royalty Plan? - Ad
Because of a change in the law, Texas could soon be the AI data center capital of the world. It's all thanks to their vast wealth in oil and gas. There's a way you could collect regular payments as a result of this Texas AI boom...
ON Semiconductor, Williams Companies And 3 Stocks To Watch Heading Into Monday
Key stocks to watch include Williams Companies, Spirit AeroSystems, Goodyear Tire & Rubber, IDEXX Laboratories, and ON Semiconductor
Dave Ramsey Reveals Why Millionaires Crush Mortgages Early
Dave Ramsey advises buying a home with cash, citing his firm's survey of millionaires who often retire their mortgages in about 10 years.
Is Nvidia About to Trigger Another 150X Opportunity? - Ad
Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic processing units. Legendary investor Louis Navellier believes this new invention could be even more revolutionary and mint a new wave of millionaires.
2026 COLA Increase: Social Security Benefits To Rise By 2.8% In 2026, Here's How Much More You Will Get Every Month
The Social Security Administration announced a 2.8% COLA increase for 2026, affecting 75 million Americans.
San Francisco mayor proposes denser housing to tackle affordability crisis
SAN FRANCISCO (AP) — San Francisco Mayor Daniel Lurie is trying to get more homes built for people like Liam Murphy: a fifth-generation city kid who found himself repeatedly outbid for tiny two-bedroom houses that wound up selling for $1.6 million.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Pizza Hut's parent company says it's considering selling the chain
Pizza Hut could soon be up for sale.
Elon Musk Calls Out Sam Altman Over Tesla Roadster Refund: 'This Issue Was Fixed and You Received a Refund Within 24 Hours'
Elon Musk and Sam Altman are once again in a public spat, this time over a car.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Billie Eilish Asks Zuckerbeg, Other Billionaires To Donate
Billie Eilish urges billionaires to share their wealth for good causes during award acceptance speech. Mark Zuckerberg in attendance.
Kevin O'Leary Said His Mom's Secret 55-Year-Old Investment Portfolio Outperformed Most Hedge Funds—He Decided Then, 'That's How I'm Going To Invest'
Shark Tank's Kevin O'Leary revealed how his mother's disciplined, 55-year investment strategy of diversification and long-term thinking shaped his own approach to building and preserving wealth.
From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad
Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.
Move Over, Musk—The World's Richest Woman Joined the $100B Club
Alice Walton, daughter of Walmart founder Sam Walton, is the richest woman in the world worth more than $100 billion.
Trump Warns Supreme Court Tariff Ruling Could 'Literally Destroy' The US: 'We'll Be Struggling For Years'
President Donald Trump warned that the U.S. economy would face significant challenges if the Supreme Court rules against the majority of the tariffs imposed this year.
How to Screw Everything Up and Get Paid for It - Ad
Elon Musk just secured a $29B handout from Tesla's board to help "keep his energies focused." It's an obscene reward when the company's much-hyped pivot from EV to AI is still unproven, and its Optimus robot has zero pre-orders. But there's a much better play here... a little-known robotics stock already landing the kinds of huge deals Tesla can only dream of.
Bloom Energy Stock Surges Nearly 17% In Wednesday Pre-Market: What's Going On?
Shares of Bloom Energy Corp soared 18.68% in pre-market trading on Wednesday as third-quarter results surpassed analyst estimates.
What to know as the annual sign-up window for health insurance arrives
Higher prices, less help and all hang over health insurance markets as shoppers start looking for coverage this week.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Boeing may face its first civil trial seeking damages for deadly Ethiopia crash
More than six years after a jetliner crashed in Ethiopia, the first civil trial stemming from the disaster that killed all 157 people on board appears poised to move forward.
Bitcoin's Downtrend Explained By Wall Street Vet: It's An 'IPO-Style Distribution'
Veteran Wall Street investor Jordi Visser said on Anthony Pompliano's podcast that the current Bitcoin (CRYPTO: BTC) price action resembles an "
Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad
Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.
Nigerian billionaire plans expansion of Africa's biggest oil refinery
ABUJA, Nigeria (AP) — The billionaire owner of plans to expand its capacity to 1.4 million barrels per day to meet growing fuel needs in the continent and beyond.
China May Have Made A Breakthrough With Solid State Batteries Offering 600-Mile+ Range, Here's What You Should Know
Chinese researchers' share breakthrough in EV battery technology with solid-state batteries offering 600+ mile range and weighing 220 lbs.
Have You Seen This Man on TV This Week? - Ad
He's been all over CNBC with his latest findings that Nvidia, Amazon and Tesla are ticking time bombs in investors' portfolios. He's a futurist known for making contrarian and highly accurate calls over the past 30+ years. Today, he's sharing the three stocks positioned to take over as the tech kingpins of tomorrow.
Trump says a Canadian ad misstated Ronald Reagan's views on tariffs. Here are the facts and context
WASHINGTON (AP) — President Donald Trump pulled out of trade talks with Canada Thursday night, furious over what he called a “fake’’ television ad from Ontario’s provincial government that quoted former U.S. President Ronald Reagan from 38 years ago criticizing tariffs -- Trump’s favorite economic tool.
Jensen Huang Explains Why He Loved His Dishwashing Job — Nvidia CEO Pours Cold Water Over Popular Idea Of Finding 'Something You Love'
Nvidia CEO Jensen Huang shares his unconventional view on passion and work, emphasizing the value of commitment and dedication in creating passion.
Texas Is All-in on AI Data Centers. Guess Who Benefits... - Ad
The state of Texas recently made a critical change to its laws... In a quest to become the AI data center capital of the world. Now, these giant buildings are popping up everywhere in Texas...
Taylor Swift, Elon Musk, Donald Trump, MrBeast — Robinhood Just Made Their Mojo Tradable
Robinhood has new prediction markets for its customers, with a focus on the entertainment sector. Here are some of the new markets.
Trump Says He Knows 'Very Little' About 'Huge' Crypto Industry, But Glad His Sons Are Involved
President Donald Trump expressed strong support for the cryptocurrency industry in an interview aired Sunday, stating that under his administration, the U.S. has emerged as the global leader in the sector.
Why Aren't You Invested in the Texas Royalty Plan? - Ad
Because of a change in the law, Texas could soon be the AI data center capital of the world. It's all thanks to their vast wealth in oil and gas. There's a way you could collect regular payments as a result of this Texas AI boom...
Energy Fuels (UUUU) Stock Is Rising Tuesday: What's Fueling The Surge?
Energy Fuels shares are trading higher on Tuesday alongside Cameco Corp, which announced a strategic partnership with the U.S. government.
Japan's Toyota, hurt by President Trump's tariffs, reports a drop in profit
TOKYO (AP) — Toyota reported a 7% year-on-year drop in its profit for April-September on Wednesday, as President Donald Trump’s tariffs slammed Japanese automakers, but it raised its forecast for the full fiscal year.
Is Nvidia About to Trigger Another 150X Opportunity? - Ad
Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic processing units. Legendary investor Louis Navellier believes this new invention could be even more revolutionary and mint a new wave of millionaires.
Nvidia, TSMC Unveil The First US-Made Blackwell Wafer, But Analyst Ming-Chi Kuo Flags This Overlooked Detail
Nvidia Corp (NASDAQ: NVDA) has introduced the first U.S.-made Blackwell wafer, a crucial component for AI chips, at Taiwan Semiconductor Manufacturing Co's (NYSE: TSM) facility in Phoenix.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.